- Home
- ALGM vs NUVL Comparison
ALGM vs NUVL Comparison
Compare ALGM & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGM
- NUVL
- Stock Information
- Founded
- ALGM 1990
- NUVL 2017
- Country
- ALGM United States
- NUVL United States
- Employees
- ALGM N/A
- NUVL N/A
- Industry
- ALGM Semiconductors
- NUVL Biotechnology: Pharmaceutical Preparations
- Sector
- ALGM Technology
- NUVL Health Care
- Exchange
- ALGM Nasdaq
- NUVL Nasdaq
- Market Cap
- ALGM 6.5B
- NUVL 5.5B
- IPO Year
- ALGM 2020
- NUVL 2021
- Fundamental
- Price
- ALGM $36.81
- NUVL $81.69
- Analyst Decision
- ALGM Buy
- NUVL Strong Buy
- Analyst Count
- ALGM 8
- NUVL 10
- Target Price
- ALGM $31.63
- NUVL $119.60
- AVG Volume (30 Days)
- ALGM 2.3M
- NUVL 569.2K
- Earning Date
- ALGM 07-31-2025
- NUVL 08-07-2025
- Dividend Yield
- ALGM N/A
- NUVL N/A
- EPS Growth
- ALGM N/A
- NUVL N/A
- EPS
- ALGM N/A
- NUVL N/A
- Revenue
- ALGM $725,006,000.00
- NUVL N/A
- Revenue This Year
- ALGM $18.36
- NUVL N/A
- Revenue Next Year
- ALGM $18.98
- NUVL N/A
- P/E Ratio
- ALGM N/A
- NUVL N/A
- Revenue Growth
- ALGM N/A
- NUVL N/A
- 52 Week Low
- ALGM $16.38
- NUVL $55.54
- 52 Week High
- ALGM $38.45
- NUVL $113.51
- Technical
- Relative Strength Index (RSI)
- ALGM 74.90
- NUVL 60.10
- Support Level
- ALGM $35.07
- NUVL $78.94
- Resistance Level
- ALGM $38.45
- NUVL $82.45
- Average True Range (ATR)
- ALGM 1.06
- NUVL 2.76
- MACD
- ALGM 0.11
- NUVL 0.27
- Stochastic Oscillator
- ALGM 79.56
- NUVL 90.66
About ALGM Allegro MicroSystems Inc.
Allegro Microsystems Inc is a designer, developer, fabless manufacturer, and marketer of sensor ICs and application-specific analog power ICs for automotive and industrial markets. Its Sensor IC allows customers to precisely measure motion, speed, position, and current, and Power ICs include high-temperature and high-voltage capable motor drivers, power management, and LED driver ICs. Its products are divided into three categories such as SENSE which includes Current Sensors, Switches and Latches, and Interface ICs among others; REGULATE which includes Regulators, ClearPower Modules, and LED Drivers; and DRIVE which includes BLDC Drivers, Brush DC, and others. Key revenue for the company is generated from Greater China and the rest from the United States, Japan, Europe, and other regions.
About NUVL Nuvalent Inc.
Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically proven kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.